Ikarian Capital, LLC Allakos Inc. Put Options Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 13, 2022	SELL	$5.08 - $9.81 $189,992 - $366,894	-37,400 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $22,959 - $33,129	-300 Reduced 0.8%	37,400 $3.96 Million
Q1 2021 May 17, 2021	BUY	$109.73 - $153.66 $844,921 - $1.18 Million	7,700 Added 25.67%	37,700 $4.33 Million
Q1 2020 May 15, 2020	BUY	$44.49 - $93.39 $1.33 Million - $2.8 Million	30,000 New	30,000 $1.34 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.